INTEGRATED CAP AND SEAL SYSTEM

Abstract
A cap and seal system for a liquid medicament container. The system comprises a cap formed from a substantially rigid material and has a retention component integrally formed therewith. A seal is formed from a material which is less hard than the cap and positioned within the cap such that, when the retaining component retains the cap on a container in use the seal is positioned such that it forms a fluid tight seal between the cap and the container. A recess is formed in the seal through which a liquid outlet channel can pass in use to access the contents of the container via the cap and the seal.
Description
FIELD

The present invention relates generally to a cap and seal system for drug delivery systems with a separate dose container. Such a system is used with a liquid medicament container into which an outlet channel is inserted in use.


BACKGROUND

Drug delivery devices with separate dose containers are designed to have a long product life. The dose container part of such systems is then used as the replaceable component. The separate dose container contains a liquid medicament, such as a liquid drug, solution suspension or colloid, whose sterility and stability must be maintained through its shelf life. However, it must be able to interface and create a robust seal with the drug delivery device through during use. Furthermore, being replaceable, the dose container should also be inexpensive. Typically, such a container is composed of a bottle and a cap, the latter interfacing with the drug delivery device. Hence, the cap must meet certain criteria, such as: no fluid exchange being allowed before the outlet channel (e.g.: needle, piston, etc.) is inserted; maintenance of a tight and leak-free seal with the outlet channel; and maintenance of a tight and leak-free seal with the container


At present, such criteria are attempted to be met by septum seals or moulded caps, but these have disadvantages. Septum seals are rubber stoppers that create an air-tight seal. They are solid and initially have no ports (e.g.: holes) through which the liquid medicament can exit. To allow the liquid to flow out, the septum must be pierced, which either requires a sharp needle, a significant user force, or both. A sharp needle reduces user safety. On the other hand, a significant force is hard to produce, which is uncomfortable to the user and may be impossible for people with physical impairments. Furthermore, the simple piercing of the septum might not result in a perfect seal.


Molded caps can achieve an air-tight steal when used in conjunction with O-rings and/or gaskets. As no part is pierced through, the operating force is much lower than with septum seals. However, multiple parts are required, which also requires additional assembly. Furthermore, die cut gaskets have high tolerances. An alternative would be to mold the gaskets, but in this case the tolerances of each individual part add up, resulting in less control of manufacturing tolerances and increased expense in manufacture.


Alternatives to simply piercing a septum are disclosed in EP0499481 and WO0057835. Such devices present a “needle” like feature. The device attaches to the container and pierces the septum. The outlet channel is then inserted through/in the device. The inherent problems to piercing a septum, such as sharp features, remain.


An improvement on the septum seal is disclosed in U.S. Pat. No. 4,084,718, where the septum is incorporated in the cap, rather than the container. However, such an invention is composed of multiple parts and still requires the piercing, potentially with a sharp needle, of a fairly thick septum.


EP0088056 does not require a septum, rather relying on compliance between the outlet channel and the container neck. However, obtaining such a seal with a rigid material requires a rather large compression force. If on the other hand, a softer material is used for the container (better compliance with the outlet channel), then barrier properties (e.g.: water/moisture, oxygen, etc.) are sacrificed. The device is also designed to contain a single dose, which is not suitable for a variety of drug delivery devices.


Moreover, most of these devices have no feature for permanent attachment of the outlet channel to the container.


Accordingly it will be appreciated that there is a need for a low cost one-part cap and sealing system to create an air-tight seal with the delivery device, without requiring significant user force.


SUMMARY

According to the present invention there is provided a cap and seal system for a liquid medicament container, the system comprising a cap formed from a substantially rigid material and having a retention component integrally formed therewith; and a seal formed from a material which is less hard than the cap and positioned within the cap such that, when the retaining component retains the cap on a container in use the seal is positioned such that it forms a fluid tight seal between the cap and the container; and a recess formed in the seal through which a liquid outlet channel can pass in use to access the contents of the container via the cap and the seal.


The present invention provides an arrangement in which a low cost cap and sealing arrangement can be provided which is fluid-tight, simple to attach to a container, and yet which can easily allow access to the contents of a container by simple low-force insertion of an access channel.





DESCRIPTION OF THE DRAWING FIGURES

Examples of the present invention will now be described with reference to the accompanying drawings, in which:



FIG. 1 is a perspective view from above of a cap and seal system according to the present invention;



FIG. 2 is a perspective view from below of a cap and seal system according to the present invention;



FIG. 3 is a side cross-sectional view of the cap and seal system of FIGS. 1 and 2 attached to a container;



FIG. 4 is a side cross-sectional view of the cap and seal system of FIGS. 1 and 2 attached to a container and with a liquid channel inserted; and



FIGS. 5 & 6 are perspective and perspective cross-sectional views of an alternative seal assembly.





DETAILED DESCRIPTION

Referring to FIGS. 1 and 2, the system of the present invention has two main elements, a cap 1 and a seal 2. The cap 1 is, for example, a polymer structure and the seal 2 may be made of an elastomer. However, these are not the only possible combination of materials. Generally, the cap 1 should be made of a substantially rigid material, since it must be able to withstand loading forces from interaction with a medical device or other external component, without substantially changing shape or creeping. On the other hand, the seal 2 should be made of a softer and pliable material, since it creates a tight seal by complying to an outside surface of the outlet channel in use. Ideally, both materials should be inexpensive to reduce the overall cost. Both parts can be co-moulded, with the latter being moulded inside the former. Co-moulding has the benefit that, since the two parts are effectively created as one, everything is done in one moulding process step. A further advantage of co-moulding is that no assembly is required and there is no need for other parts, such as O-rings or gaskets. Furthermore, because the seal 2 is moulded against/inside the cap 1, the individual tolerances are defined solely by any moulding tool, resulting in better control of those tolerances.


The cap 1 and seal 2 can each be manufactured independently or in combination using a moulding process adapted according to the material selection. Known moulding techniques that are suitable for production of these components include vacuum forming, thermoplastic or metal injection moulding, thermosetting injection, compression moulding and transfer moulding. The cap 1 and/or the seal 2 could alternatively be produced using additive manufacturing techniques such as Fused Deposition Modelling, Fused Filament Fabrication, Stereolithography, Selective Laser Sintering or other 3D additive manufacturing processes. A wide variety of materials, including thermoplastics, photopolymers, wax, polycarbonate, and even metals, such as aluminium, titanium and nickel, or ceramics may be deployed using these manufacturing methods.



FIG. 1 shows an example of the cap 1 that can be produced by molding. The lower part of the cap 1 is constructed to interface with a container 3, in this case a bottle, by housing the neck. As shown in FIG. 2, the cap 1 is shaped to provide seating for the seal 2, which may be contained inside the lower region of the cap 1, against the lower surface of the upper region of the cap 1. The cap 1 can be manufactured by molding, or by additive manufacturing as described earlier. If required, the seal 2 may be produced by the same or by a separate manufacturing step or process. As further shown in FIG. 2, the region of the cap 1 around the seal 2 includes a retainer that contains internal snap features 4 to keep the container 3 attached to the cap 1 in use. It may, as shown, also feature windows 5 for seal molding.



FIG. 1 further shows that the upper region of the cap features an internal hole 6 through which an outlet channel 7 (shown in FIG. 4) can be inserted. The cross section of the internal hole may vary along its axis to better suit the geometry of the outlet channel 7 and/or guide the outlet channel through the hole 6. For example, the tapered profile of internal hole 6 illustrated in FIG. 3 allows for insertion guidance, while minimising scraping because of the high steepness. This tapering may be a linear taper, a curved taper or comprise a compound-shaped taper to optimally provide the function of guiding the outlet channel 7 into, and through, the cap hole 6. Externally, the cap 1 may contain any number of features to help with the delivery system operation, such as grooves to interface with a moving piston or other parts. A further seal (not shown) can be formed over the top surface of the cap 1 and cap hole 6 to isolate and therefore protect the medicament from, for example, moisture and air ingress to maintain its sterility and stability before it is used. Such a seal may be formed by applying a foil or film coating over the upper surface of the upper cap.


The seal part 2 resides within the cap structure 1. It functions to provide a secure seal 9 with the medicament bottle once the cap 1 has been snapped into place. The seal additionally functions to create a tight and leak-free seal with the outlet channel 7, when inserted. Advantageously, the seal 2 may be co-molded with the cap 1, avoiding the need for assembly as well as providing beneficial manufacturing tolerances. However, the seal component 2 can be manufactured in a separate step or process than that used for production of the cap 1. Such a situation may be beneficial if the materials selected for each component have significantly different properties.


When the outlet channel 7 is inserted, the seal is achieved by a squeezing of the walls of seal hole 11. Before the outlet channel 7 is inserted, the minimum diameter of the seal hole 11 is smaller than the outside diameter of the outlet channel 7. After the outlet channel 7 is inserted, the diameter of the seal hole 11 is equal to the outside diameter of the outlet channel 7. The normal stress resulting from the compression of the walls creates a tight and leak-free seal with the outside surface of the outlet channel 7. As mentioned above, the cross section of the seal hole may vary along its axis to better suit the geometry of the outlet channel 7 and/or guide the outlet channel 7 through the seal hole 11.


The seal 9 is achieved with the container 3 via compression of an upper surface of the container 3 against the outside lower surface of seal part 2. In a case with no container 3 inserted, the distance between the upper surface of the snap features 4 of the cap structure and the outside lower surface of seal part 2 is smaller than the distance between the corresponding surfaces of the neck of the container 3. When the container 3 is inserted, the neck and the seal are compressed, generating a contact force, which effectively seals the container in a fluid tight manner.


Optionally, but advantageously, the seal hole 11 may feature a thin septum barrier 10 with the objective of having a further protection layer for the liquid medicament. This barrier 10 is broken during insertion of the liquid outlet channel 7, preferably requiring a minimal amount of additional force. In contrast to a common septum seal that is bulky, large, and fairly thick, the septum barrier 10 can be very small and thin, which does not significantly increase the piercing force and therefore allows the use of a blunt outlet channel 7 such as a capillary, dip or other tube as well as other alternatives such as needles and other sharpened outlet channels. Furthermore, the seal with the outlet channel 7 is defined by the geometry of the seal hole 11 and not the geometry of any gap that is created, and hence will not be affected by the variability inherent in piercing.


In combination, the above-described cap 1 and seal 2 structures provide numerous advantages for use with a medicament container 3, such as a bottle. Each component may be manufactured independently using processes that are optimised for the selection of each specific material. The cap 1 must be strong enough to provide a sufficiently rugged interface with the mechanical instrument into which the medicament container 3 will be inserted. Suitable materials are polymers, thermoplastics and even metals. The seal 2 must be soft and pliable enough to form a compliant seal with the outer surface of the outlet channel 7. The seal 2 might readily be formed using a molding process, whereas the cap might be best manufactured using an additive manufacturing process or a different molding process.


Advantageously, however, the choice of materials will be made such that both cap 1 and seal 2 may be co-molded, such as polypropylene for the cap 1 and a thermoplastic elastomer for the seal 2. Due to its lower cost, this method is very advantageous for large-scale production. Alternatively, the choice may be made such that both the cap 1 and seal 2 may be produced using additive manufacturing techniques.


The structure of the combined cap 1 and seal 2 is such that the internal snap features 4 of the cap 1 form a secure mounting to the container 3, while the soft and pliant seal 2 forms a seal once the cap 1 and seal 2 combination has been snapped into place.


When thus assembled, any external seal over the cap hole 6 is pierced, typically by insertion of the outlet channel 7, the cap hole 6 guides the outlet channel 7 into and through the cap 1. When combined with the seal 2, the outlet channel 7 is thus guided into the seal hole 11, requiring some increased frictional force resulting from the seal hole diameter being smaller than the outlet channel external diameter. The combination of seal 2 and narrower seal hole diameter provide protection such that a thin septum barrier 10 can be incorporated within or, at the top or bottom edge of, the seal hole 11 to provide a further level of protection for the medicament inside the container 3. This thin septum barrier 10 may alternatively be formed directly over the surface of the container 3, such that it abuts the base of the seal hole 11 when the cap 1 and seal 2 combination is snapped into position.


As stated above, a preferred embodiment features a co-molded cap 1 and seal 2 for use with a medicament container 3 comprising a single chamber. As also described above, the cap 1 and seal 2 may be manufactured independently using any known manufacturing technique and then assembled. For example, FIGS. 5 and 6 show a seal 2 that is moulded separately from the cap (not shown). This embodiment presents snap features 12 on seal 2 that serve to join the seal 2 with cap 1. They are assembled by pushing the seal 2 into the cap, where the seal's snaps 12 fit with snap features 4 in cap 1. Some medicaments may optimally be delivered using multiple chambers, for example a concentrated active compound which is mixed at the time of dispensing with a liquid solvent or base medium. A multi-chambered container can thus be used with the techniques described herein, having a cap with two (or more) holes for discrete outlet channels, one per chamber, and associated seal structure or structures aligned with the cap holes and optimised for the respective outlet channels associated with each chamber. Application of a thin septum seal layer over the top of each chamber can prevent cross contamination during assembly of the container, cap, and seal combination.

Claims
  • 1. A cap and seal system for a liquid medicament container, the system comprising: a cap formed from a substantially rigid material and having a retainer integrally formed therewith, wherein an upper region of the cap comprises an internal hole into which a liquid outlet channel is inserted; anda seal, formed from a pliable material that is less rigid than the cap, is positioned within a lower region of the cap such that, when the retainer attaches the cap on a container, the seal forms a fluid tight seal between the cap and the container; anda seal hole formed in the seal through which the liquid outlet channel passes to access a liquid within the container via the cap and the seal, wherein the internal hole and the seal hole are in vertical alignment with each other such that the internal hole is located above the seal hole.
Priority Claims (1)
Number Date Country Kind
1610368.1 Jun 2016 GB national
RELATED APPLICATION

The present application is a continuation application of U.S. patent application Ser. No. 16/310,190, filed 14 Dec. 2018, now U.S. Pat. No. 11,529,288, issued Dec. 20, 2022, which is a national stage application under 35 U.S.C. § 371 of International Application No. PCT/GB2017/051703, filed 12 Jun. 2017, which claims priority to Great Britain Patent Application No. 1610368.1, filed 15 Jun. 2016. The above referenced applications are hereby incorporated by reference into the present application in their entirety.

Continuations (1)
Number Date Country
Parent 16310190 Dec 2018 US
Child 18077519 US